CVS Health Corporation $CVS Shares Acquired by Sterling Capital Management LLC

Sterling Capital Management LLC raised its holdings in shares of CVS Health Corporation (NYSE:CVS) by 12.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 128,075 shares of the pharmacy operator’s stock after acquiring an additional 13,948 shares during the period. Sterling Capital Management LLC’s holdings in CVS Health were worth $10,975,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. BlackRock Inc. bought a new position in shares of CVS Health during the 2nd quarter valued at $12,747,462,000. State Street Corp lifted its stake in CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after purchasing an additional 15,604,883 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after buying an additional 11,233,381 shares during the last quarter. Bank of America Corp DE grew its stake in shares of CVS Health by 148.0% during the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after buying an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC purchased a new position in shares of CVS Health in the second quarter worth about $1,217,558,000. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CVS shares. Wells Fargo & Company boosted their target price on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. BMO Capital Markets set a $112.00 price objective on CVS Health in a research report on Wednesday, September 9th. Truist Financial increased their price objective on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Sanford C. Bernstein restated an “outperform” rating and issued a $112.00 target price on shares of CVS Health in a report on Wednesday, September 9th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of CVS Health in a research note on Friday, October 9th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $107.80.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analyst price target maintained: Cantor Fitzgerald kept its $110 price target for CVS, implying confidence in further upside from recent trading levels. Cantor Fitzgerald maintains CVS price target
• Positive Sentiment: Expanded fall merchandise: CVS Pharmacy is adding collectibles, limited-edition products, beauty items, snacks and seasonal offerings across stores and CVS.com. The initiative could support front-store traffic and retail sales, although its financial impact is not yet quantified. CVS expands fall assortment
• Positive Sentiment: New clinic openings: CVS reportedly opened three clinics, supporting its broader healthcare-services strategy and potentially increasing patient engagement and revenue opportunities. CVS opens three clinics
• Neutral Sentiment: Unusually high call-option activity: Traders purchased 51,620 call options, about 203% above average. This signals increased speculative interest and may indicate bullish positioning, but options activity alone does not establish a change in CVS’s fundamentals.
• Neutral Sentiment: Analyst attention remains elevated: Zacks highlighted CVS as a heavily watched stock but did not provide a definitive new buy catalyst. Investors continue to weigh the company’s latest strong earnings performance against execution risks in its healthcare businesses. Zacks analysis of CVS
• Negative Sentiment: Recent underperformance: CVS previously declined even as the broader market gained, indicating lingering investor concerns or a lack of a fresh catalyst. The company’s strong latest quarterly results and fiscal 2026 earnings guidance provide support, but investors may remain focused on whether that performance is sustainable.

CVS Health Trading Down 1.0%

Shares of NYSE CVS traded down $0.94 during trading hours on Friday, hitting $93.55. The company’s stock had a trading volume of 4,601,538 shares, compared to its average volume of 9,303,546. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The stock has a market cap of $119.64 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 0.88 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The business has a 50-day simple moving average of $91.60 and a 200-day simple moving average of $93.78.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the prior year, the company posted $1.81 EPS. CVS Health’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.